Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients

Mohammadarian Akbari1, Mehdi Akhavan-Bahabadi2, Navid Shafigh3

  • 1Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Cytokine
|March 26, 2022
PubMed

Insights

Tyrosine kinase 2 (TYK2) was down-regulated in male COVID-19 patients, suggesting a role in impaired interferon responses. This finding may explain SARS-CoV-2

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Tyrosine kinase 2 (TYK2), a member of the JAK family, is vital for immune response regulation.
  • TYK2 influences the expression of IFNAR1 and the initiation of type I interferon signaling.
  • Dysregulated immune responses are implicated in the pathogenesis of COVID-19.

Purpose of the Study:

  • To investigate the expression levels of TYK2 and IFNAR1 in COVID-19 patients.
  • To determine if TYK2 and IFNAR1 levels correlate with disease severity or differentiate cases from controls.

Main Methods:

  • Quantitative analysis of TYK2 and IFNAR1 gene expression in venous blood samples.
  • Comparison of expression levels between COVID-19 patients (male/female, ICU/non-ICU) and matched controls.
  • Statistical analysis to assess differential expression and diagnostic potential.

Main Results:

  • TYK2 expression was significantly down-regulated in male COVID-19 patients compared to male controls (RME = 0.34, P = 0.03).
  • No significant differences in TYK2 or IFNAR1 levels were observed between female cases and controls, or based on ICU admission.
  • Neither TYK2 nor IFNAR1 transcripts could reliably differentiate COVID-19 cases from controls or predict disease severity.

Conclusions:

  • Down-regulation of TYK2 in male COVID-19 patients may represent a molecular mechanism contributing to the impaired type I interferon response observed in SARS-CoV-2 infection.
  • IFNAR1 expression does not appear to be a significant factor in COVID-19 pathogenesis or severity in this cohort.
  • Further research is warranted to explore the precise role of TYK2 in SARS-CoV-2 and its potential as a biomarker.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.1K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K